Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02138721 | Local Treatment With RP for Newly-diagnosed mPCa(LoMP) | unknown | N/A | 80 | University Hospital, GhentOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT05150236 | EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC(ANZUP2001) | unknown | Phase 2 | 93 | Australian and New Zealand Urogenital and Prostate Cancer Trials GroupOTHER |
| 1 |
| Dec 15, 2023 |
| clinicaltrials |
| NCT06029036 | A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer | unknown | Phase 2 | 53 | Peking University First HospitalOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT05063760 | Exercise in Testicular Germ Cell Cancer Survivors(ExCell) | unknown | N/A | 60 | Slovak Academy of SciencesOTHER_GOV | 1 | Dec 5, 2023 | clinicaltrials |
| NCT06154499 | Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery | unknown | — | 1,784 | IRCCS San RaffaeleOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT02594072 | Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)(ASSERT) | unknown | N/A | 80 | University of British ColumbiaOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT02935205 | Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 38 | Mamta ParikhOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT05732948 | PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer | unknown | Phase 1 | 12 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdINDUSTRY | 1 | Nov 29, 2023 | clinicaltrials |
| NCT06099977 | Binaural Sound for Remimazolam Induction | unknown | N/A | 72 | Gangnam Severance HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05453604 | Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications(URODETECT-WP1) | unknown | N/A | 105 | Novosanis NVINDUSTRY | 1 | Nov 13, 2023 | clinicaltrials |
| NCT05069467 | Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL)(AVAIL) | unknown | N/A | 120 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT05580107 | MDPK67b in Patients With Prostate Cancer | unknown | Phase 1 | 15 | Med Discovery SAINDUSTRY | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06117696 | Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)(CartDiagPROST) | unknown | — | 90 | Direction Centrale du Service de Santé des ArméesOTHER | 2 | Nov 7, 2023 | clinicaltrials |
| NCT05961514 | the Beijing Randomized Study Of Prostate Cancer Screening(BROPCS) | unknown | N/A | 30,000 | Peking University Cancer Hospital & InstituteOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT04097002 | First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. | unknown | Phase 1 / Phase 2 | 24 | Orca Therapeutics B.V.INDUSTRY | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04100811 | Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform | unknown | — | 2,019 | miR Scientific LLCINDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT04661176 | Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico | unknown | — | 500 | miR Scientific LLCINDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT06091072 | Image-guided Navigation During Robotic Sentinel Node Removal(N21LND) | unknown | N/A | 55 | The Netherlands Cancer InstituteOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT04394676 | The Impact of Low Pressure Pneumo in RARP II | unknown | N/A | 600 | Metro Health, MichiganOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT05555017 | Tracer-Guided Surgery for Recurrent Prostate Cancer(Trace-II) | unknown | Phase 2 | 60 | The Netherlands Cancer InstituteOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06065592 | Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms(CAT_PB) | unknown | Phase 1 | 500 | Lebanese UniversityOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT05020522 | Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate Cancer(CLIMATE) | unknown | N/A | 702 | University College, LondonOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT06062355 | Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer | unknown | Phase 1 | 9 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 0 | Oct 2, 2023 | clinicaltrials |
| NCT01949337 | Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer | unknown | Phase 3 | 1,311 | Alliance for Clinical Trials in OncologyOTHER | 3 | Sep 28, 2023 | clinicaltrials |
| NCT04393376 | PSA Glycomics Assay for Early Detection of Prostate Cancer | unknown | N/A | 150 | Prof.dr. H.P. BeerlageOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT05919524 | SBRT With Focal Dose Escalation on DIL in Localized Prostate Cancer(SAFO) | unknown | N/A | 27 | Almudena ZapateroOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT06054789 | Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer | unknown | N/A | 8 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT06050239 | Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer | unknown | Early Phase 1 | 10 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT04831541 | 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer | unknown | Early Phase 1 | 600 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06034431 | Increasing Access to Definitive Treatment for Prostate Cancer | unknown | N/A | 150 | Brigham and Women's HospitalOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT03253978 | SPORT High-Risk Trial Evaluating SABR in Prostate Cancer(SPORT) | unknown | N/A | 40 | Belfast Health and Social Care TrustOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT03948204 | Quality of Life and Shared Decision Making in Prostate Cancer | unknown | — | 10,000 | Norwegian Institute of Public HealthOTHER_GOV | 1 | Sep 1, 2023 | clinicaltrials |
| NCT05840549 | A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement(CO-STAR) | unknown | N/A | 45 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04832113 | Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate Cancer(ETADAPT) | unknown | N/A | 216 | Centre Leon BerardOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT06006104 | Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer | unknown | Phase 1 / Phase 2 | 49 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 0 | Aug 23, 2023 | clinicaltrials |
| NCT05996289 | Inter-observer Variability in the Segmentation of Prostate Tumour Lesions Using Multiparametric MRI (VARIOP)(VARIOP) | unknown | — | 70 | University Hospital, BrestOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05982418 | Improvement of RARP Outcomes Via 3D Printed/Virtual Prostate Models(RARP-3D) | unknown | N/A | 162 | Guy's and St Thomas' NHS Foundation TrustOTHER | 0 | Aug 8, 2023 | clinicaltrials |
| NCT05900973 | A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer | unknown | Phase 2 | 19 | D'Or Institute for Research and EducationOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05462392 | Robot-assisted Urological Surgeries Using the MicroHand S Robot | unknown | N/A | 136 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05973149 | Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer | unknown | Phase 1 | 108 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05558956 | Total Body PET-CT Imaging of Prostate Cancer Using Illuccix | unknown | Early Phase 1 | 100 | BAMF HealthOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05957653 | Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort | unknown | Phase 4 | 140 | RenJi HospitalOTHER | 0 | Jul 24, 2023 | clinicaltrials |
| NCT05955209 | Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC) | unknown | Phase 2 | 40 | Peking University Cancer Hospital & InstituteOTHER | 0 | Jul 21, 2023 | clinicaltrials |
| NCT05955677 | Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 100 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05739812 | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | unknown | N/A | 100 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05941104 | The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy | unknown | — | 100 | Anhui Provincial HospitalOTHER_GOV | 0 | Jul 12, 2023 | clinicaltrials |
| NCT05223218 | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | unknown | — | 500 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05928377 | Unveiling Patient Experiences in Testicular Cancer Clinical Trials | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT01913717 | Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion | unknown | N/A | 65 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT02672449 | Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer | unknown | N/A | 65 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Dec 20, 2023source: clinicaltrials